Features August 2010 Issue

Cardiovascular Risks Mount with Certain Anti-Inflammatory Drugs

Cardiovascular Risks Mount with Certain Anti-Inflammatory Drugs

A recent analysis of data from more than a million users of nonsteroidal anti-inflammatory drugs (NSAIDs) underscores the importance of careful selection and use of the medications, because they can vary widely in the risks they pose to patients. In the cohort study out of Denmark, the use of diclofenac (Cataflam, Voltaren) was associated with a 91 percent increase in the relative risk of a fatal heart attack or stroke in healthy adults.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.